NSEAmendment to AOA/MOA1d ago · 1 Oct 2026, 09:28 pm
Amendment to AOA/MOA
Aarti Surfactants Limited · AARTISURF
✦ AI Summary
Aarti Surfactants Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company, which includes alteration of the Main Object Clause of the Memorandum of Association.
Analysis Scores
Earnings Impact2/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Aarti Surfactants Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.
Attachments (1)
📄pdf
Download →
AARTISURF_01102026212842_AARTISURF.pdf
View document text
October 1, 2026
To, To,
Listing / Compliance Department Listing / Compliance Department
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers “Exchange Plaza”, Plot No C/1,
Dalal Street, Mumbai 400 001. G Block, Bandra Kurla Complex,
Bandra (E), Mumbai 400 051.
Scrip Code: 543210 Symbol: AARTISURF
Dear Sir / Madam,
Sub: Alteration of Main Object Clause of the Memorandum of Association of the Company
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015, and based on the report of the Scrutinizer dated September 30, 2026, we wish to inform you that
the Members of the Company at the 8th Annual General Meeting (“AGM”) held on Tuesday,
September 29, 2026 at 04:00 P.M. (IST) through Video Conferencing / Other Audio-Visual Means, have
approved the alteration of Main Object Clause of the Memorandum of Association of the Company,
as set out in the Explanatory Statement annexed to the Notice convening the 8th AGM.
The requisite details relating to the alteration, pursuant to Regulation 30 of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III and SEBI Master
Circular dated January 30, 2026, is annexed hereto as Annexure A.
We shall submit a copy of the altered Memorandum of Association of the Company upon receipt of
the requisite approval from the appropriate regulatory authorities.
The above information is also available on the website of the Company at www.aarti-surfactants.com.
Kindly take the same on your record.
Thanking you,
Yours faithfully,
For Aarti Surfactants Limited
Priyanka Chaurasia
Company Secretary
ICSI M. NO. A44258
Annexure A
Alteration of the Main Object Clause (Clause 3, Sub-clause A) of the Memorandum of Association
(“MOA”) of the Company by way of substitution of the existing Clause 3A with the following new
Clause 3A after incorporating the additional words and corrections as under:
3. (A) To carry on the business of manufacturers, producers, processors, buyers, sellers,
importers, exporters, stockists, agents, merchants, distributors, repackers and/or otherwise
dealers in all kinds of basic drugs, dyestuffs, analytical chemicals, bulk drugs, pharmaceuticals,
medicines, surfactants, speciality chemicals and allied chemicals, including fine chemicals,
industrial and pure chemicals, organic and inorganic chemicals, aroma chemicals, biological
and biochemical products, electrolytic drugs, ingredients, products and compounds; perfumes,
toilet goods, detergents, food flavours, solvents, pure drug solvents, chemical, dye and drug
intermediates, cosmetics, insecticides, pesticides, fertilizers, heavy chemicals, alkalis, acids,
industrial chemicals and preparations, chemicals used in plastics, pigments, varnishes, paints,
alcohols, dyes and colours, agrochemicals, petrochemicals and other chemical preparations
required or used by various industries, including sugar, tanning, textile, metallurgical, process
and allied industries; proofing materials, disinfectants, oils, cotton, wetting-out agents, soaps,
tallow, gums, varnishes, synthetics, resins, catalytic agents, petroleum products and other
articles, substances and compounds of every description; and chemicals and chemical
preparations used in or required for the manufacture, processing or formulation of
pharmaceuticals, drugs, enzymes, dyes, medicines, biological and biochemical products and
other allied products, and to manufacture, deal in, process, formulate, prepare, develop,
distribute and market all kinds of chemicals and their by-products, intermediates, derivatives,
compounds, formulations, preparations and articles of the aforesaid nature, whether within or
outside India.